Lifordi Immunotherapeutics

Lifordi

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with autoimmune and inflammatory disorders.

Conveyor Therapeutics

This biotech company develops antibody drug conjugates to deliver immunosuppressive payloads for the treatment of immunological and inflammatory diseases in human patients.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Rhapsogen

This biotechnology company develops precision biologic therapeutics to treat autoimmune diseases by modulating antibody effector functions for patients with inflammatory conditions.

Aeglea BioTherapeutics

This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.